HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,607 | +3.9% | 351 | -7.6% | 0.00% | 0.0% |
Q2 2023 | $39,083 | +2.0% | 380 | +8.3% | 0.00% | 0.0% |
Q1 2023 | $38,308 | -9.3% | 351 | -5.4% | 0.00% | -50.0% |
Q4 2022 | $42,219 | +101.0% | 371 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $21,000 | -46.2% | 371 | -26.2% | 0.00% | 0.0% |
Q2 2022 | $39,000 | -25.0% | 503 | +2.9% | 0.00% | -66.7% |
Q1 2022 | $52,000 | -62.9% | 489 | -62.4% | 0.00% | -25.0% |
Q4 2021 | $140,000 | -7.3% | 1,301 | -5.9% | 0.00% | -20.0% |
Q3 2021 | $151,000 | +79.8% | 1,383 | +51.5% | 0.01% | 0.0% |
Q2 2021 | $84,000 | -6.7% | 913 | -8.1% | 0.01% | 0.0% |
Q1 2021 | $90,000 | +1700.0% | 993 | +1279.2% | 0.01% | – |
Q4 2020 | $5,000 | -37.5% | 72 | -36.8% | 0.00% | -100.0% |
Q3 2020 | $8,000 | -20.0% | 114 | -37.0% | 0.00% | 0.0% |
Q2 2020 | $10,000 | +11.1% | 181 | -40.8% | 0.00% | 0.0% |
Q1 2020 | $9,000 | -55.0% | 306 | -44.6% | 0.00% | 0.0% |
Q4 2019 | $20,000 | +33.3% | 552 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $15,000 | – | 552 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |